Dr. Pamela Leece
Public Health Physician
Health Promotion, Chronic Disease and Injury Prevention
"PHO’s partners in policy, public health, and health care are currently facing complex challenges to effectively address drug-related deaths and substance use disorders in the province. PHO’s role in providing scientific and technical advice will support informed decision-making and innovative approaches to improve the health of the population related these issues. Responding to these important health issues will require strong collaboration and integrated work with other health and social services and PHO is in an ideal position to lend public health expertise to the development of effective solutions."
Areas of Expertise
- substance use disorders, harm reduction and overdose prevention
- public health
- health services
- quality improvement and knowledge translation
- program evaluation
Appointments
Clinical Associate, Women’s College Hospital, Substance Use Service
Clinical Academic Appointment (part-time), Department of Family and Community Medicine, University of Toronto
Academic Degrees and Accreditations
- Doctor of Medicine, University of Ottawa
- Master of Science (Health Research Methodology), McMaster University
- Fellow, The Royal College of Physicians of Canada (FRCPC), Public Health and Preventive Medicine Residency Program, Dalla Lana School of Public Health, University of Toronto
- College of Family Physicians of Canada (CCFP), Family Medicine Residency Program, Department of Family and Community Medicine, University of Toronto
PHO Research Interests
- substance use disorders, harm reduction and overdose prevention
- public health
- health services
- quality improvement and knowledge translation
- program evaluation
PHO Research Activities
- Co-leading on the development and evaluation of tools to improve Canadian family physicians’ knowledge and performance in safer prescribing of opioids for chronic pain.
- Collaborating on the Surviving Opioid Overdose with Naloxone Education and Resuscitation (SOON-ER) trial: a randomized study of an opioid overdose education and naloxone distribution intervention for laypeople in ambulatory and inpatient settings.
- Collaborating to describe the clustering of opioid agonist treatment among physicians in Ontario.
- Collaborating to describe the quality of primary care for patients on opioid maintenance therapy in Ontario, Canada.
- Collaborating to describe access to opioid maintenance treatment and treatment retention for patients entering residential programs in Ontario for opioid addiction.
- Collaborating on assessment of conflict of interest among opioid prescribing guidelines.
Selected Publications
- Ontario Agency for Health Protection and Promotion (Public Health Ontario). Applying situational assessment skills to address opioid-related harms: workshop report. Toronto, ON: Queen's Printer for Ontario; 2017.
- Ontario Agency for Health Protection and Promotion (Public Health Ontario), Leece P. Evidence brief: Mortality following non-fatal opioid overdose. Toronto, ON: Queen’s Printer for Ontario; 2017.
- Ontario Agency for Health Protection and Promotion (Public Health Ontario), Cadieux G, Leece P. Evidence brief: Driving under the influence of cannabis and risk of motor vehicle collision. Toronto, ON: Queen’s Printer for Ontario; 2017.
- Ontario Agency for Health Protection and Promotion (Public Health Ontario), Meyer W, Leece P. Evidence brief: risk factors for simultaneous use of alcohol and cannabis. Toronto, ON: Queen's Printer for Ontario; 2018.
- Ontario Agency for Health Protection and Promotion (Public Health Ontario), Cadieux G, Leece P. Evidence brief: Driving under the influence of cannabis – risk factors and preventive interventions. Toronto, ON: Queen’s Printer for Ontario; 2017.
MyPHO
Don’t have a MyPHO account? Register Now